Sharp Shalini (CIK 1377202) reported 4 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-15). Recent activity: Buy ONC (18,980 shares), Buy NBIX (1,659 shares), Buy BGNE (10,985 shares), Buy NBIX (1,435 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | Director | Buy | 18,980 | $0 |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,659 | $0 |
| 2025-05-22 | BeiGene, Ltd. (BGNE) | Director | Buy | 10,985 | $0 |
| 2025-05-22 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,435 | $0 |
Source: SEC Form 4 filings · as of 2026-06-15